GeneXpert Performance Evaluation for Linkage to Tuberculosis Care

niversity of California San Francisco0 个研究点目标入组 5,500 人开始时间: 2016年9月3日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•1. (Site-level) Use standard (multi-day) sputum smear microscopy as the primary method of TB diagnosis
•2. (Site-level) Participate in NTP-sponsored external quality assurance (EQA) for sputum smear microscopy
•3. (Site-level) Send samples to a district or regional hospital/health center for Xpert testing
•4. (Patient-level) Initiate evaluation for active TB at a study health center

•1. (Site-level) Do not agree to be randomized to standard-of-care vs. intervention arms
•2. (Site-level) Perform sputum smear examination on <150 patients per year (based on 2015 data)
•3. (Site-level) Diagnose <15 smear-positive TB cases per year (based on 2015 data)
•4. (Patient-level) Have sputum collected for monitoring of response to anti-TB therapy
•5. (Patient-level) Have sputum collected as part of active, community-based case finding (e.g., contact tracing, community outreach campaign)
•6. (Patient-level) Referred to a study health center for TB treatment after a diagnosis is established elsewhere
•7. (Patient-level) Started on TB treatment for extra-pulmonary TB only

发起方

niversity of California San Francisco